The power of a standardized bleeding score in diagnosing paediatric type 1 von Willebrand's disease and platelet function defects

Haemophilia

Volumn 17, Issue 2, 2011, Pages 223-227

  Marcus, P D ^a   Nire, K G ^b   Grooms, L ^c   Klima, J ^b   O'brien, S H ^b,c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Bleeding score; Paediatric; Platelet function defects; Von Willebrand's disease

Indexed keywords

ANTIGEN; RISTOCETIN; RISTOCETIN COFACTOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADOLESCENT; ARTICLE; BLEEDING DISORDER; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ELECTRON MICROSCOPY; EPISTAXIS; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PEDIATRIC HOSPITAL; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SCORING SYSTEM; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SKIN BLEEDING; STANDARD; THROMBOCYTE AGGREGATION; THROMBOCYTE ANOMALY; VICENZA SCORE; VON WILLEBRAND DISEASE;

ADOLESCENT; BLOOD PLATELET DISORDERS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEMORRHAGE; HUMANS; INFANT; MALE; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; VON WILLEBRAND DISEASE, TYPE 1;

EID: 79951805452     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02390.x     Document Type: Article

References (12)

1. Tosetto A, Rodeghiero F, Castaman G et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2005; 4: 766-73.
2. Rodeghiero F, Castaman G, Tosetto A et al. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost 2005; 3: 2619-26.
3. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
4. Laffan M, Brown SA, Collins PW et al. The diagnosis of von Willebrand disease; a guideline from the UK Haemophilia Centre Doctors' Organization. Haemophilia 2004; 10: 199-217.
5. Sadler JE, Rodeghiero F. Provisional criteria for the diagnosis of VWD type 1. J Thromb Haemost 2005; 3: 775-7.
6. Montgomery RR. von Willebrand disease - the relevance of history. J Thromb Haemost 2005; 3: 2617-8.
7. Bowman M, Riddel J, Rand ML et al. Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire. J Thromb Haemost 2009; 7: 1418-21.
8. Biss TT, Blanchette VS, Clark DS et al. Quantitation of bleeding symptoms in children with von Willebrand Disease: use of a standardized pediatric bleeding questionnaire. J Thromb Haemost 2010; 8: 950-6.
9. Biss TT, Blanchette VS, Clark DS, Wakefield CD, James PD, Rand ML. Use of a quantitative pediatric bleeding questionnaire to assess mucocutaneous bleeding symptoms in children with a platelet function disorder. J Thromb Haemost 2010; 8: 1416-9.
10. Tosetto A. Bleeding scores. In: EU Fifth Framework. The University of Sheffield, 2000. Available at: Accessed August 12, 2009.
11. National Heart, Lung, and Blood Institute. The Diagnosis, Evaluation, and Management of von Willebrand Disease. Bethesda, MD: National Institute of Health. NIH Pub. No. 08-5832. December, 2007.
12. Favaloro Emmanuel J. Investigating people with mucocutaneous bleeding suggestive of primary hemostatic defects: a low likelihood of a definitive diagnosis?. Haematologica 2007; 92: 292-6.